Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug
Authors:
- Pierre ThérouxPTPierre Théroux
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Variability in platelet responsiveness to clopidogrel among 544 individualsJACC, 2005
- The impact of peripheral arterial disease on circulating plateletsThrombosis Research, 2004
- Clopidogrel ResistanceCirculation, 2004
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndromeJACC, 2004
- Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventionsEuropean Heart Journal, 2004
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosisPlatelets, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet actionJournal of Vascular Surgery, 2002